CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo
{{output}}
Monoclonal antibody therapies have transformed the lives of patients across a diverse range of diseases. However, antibodies can usually only access extracellular proteins, including the extracellular portions of membrane proteins that are expressed on the cel... ...
